Dramatic clinical response in the treatment of small cell glioblastoma multiforme

WHAT IS KNOWN AND OBJECTIVE: Small cell glioblastoma (scGBM) is a rare subtype of primary glioblastoma, which typically behave more aggressively compared with classical glioblastoma (GBMs). They are generally associated with poor responses to treatment, and optimal treatment is not known. CASE SUMMA...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaman, Farzana Yasmin, McLean, Catriona, Ameratunga, Malaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303203/
https://www.ncbi.nlm.nih.gov/pubmed/35018664
http://dx.doi.org/10.1111/jcpt.13608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303203/
https://www.ncbi.nlm.nih.gov/pubmed/35018664
http://dx.doi.org/10.1111/jcpt.13608

Ejemplares similares